Introduction
============

Generalized anxiety disorder (GAD) patients suffer from excessive anxiety and apprehensive expectations, they are hyperresponsive to threat and have the tendency to react negatively to situations that are uncertain ([@nsx103-B16]; [@nsx103-B9]). Sustained anticipatory anxiety constitutes a core symptom of GAD and appears to facilitate the development and maintenance of the disorder ([@nsx103-B50]).

Previous research on sustained anticipatory anxiety in rodents and nonanxious controls (HC) revealed a neural dissociation of phasic and sustained brain responses to threat anticipation ([@nsx103-B10]; [@nsx103-B13]; [@nsx103-B24]). While phasic threat responding appears to be mediated by the amygdala, sustained threat responding seems related to activity in the bed nucleus of the stria terminalis (BNST) ([@nsx103-B10]; [@nsx103-B2]). As part of the so-called extended amygdala, the BNST seems to mediate sustained hypervigilance and preparedness in the context of prolonged threat exposure (Davis et al., 2010; [@nsx103-B14]; [@nsx103-B28]). Emerging evidence in psychiatric patients stresses the role of the BNST in the pathophysiology of anxiety/stress disorders and accentuates it to be a marker of pathological anticipatory anxiety ([@nsx103-B44]; [@nsx103-B36]; [@nsx103-B6], [@nsx103-B7]). Accordingly, it has been hypothesized that sustained anticipatory anxiety in GAD patients may be linked to alterations in BNST activity ([@nsx103-B49]; [@nsx103-B25]). More specifically, pathological apprehensive expectations were hypothesized to induce hyperactivity in the BNST, through which a continuous anxious state would be maintained in patients ([@nsx103-B25]). Following that, the BNST may be a key region underlying the maintenance and possibly also the development of maladaptive anticipatory anxiety in GAD. Surprisingly, to date, no firm evidence of BNST activity alterations in GAD patients has been reported yet. There is only preliminary evidence of deviating phasic amygdala activity in GAD patients during short-term threat anticipation and conditions of uncertainty ([@nsx103-B39]; [@nsx103-B49]). Relative to HC, [@nsx103-B39] observed increased amygdala activity in GAD patients during short-term threat anticipation (between 2.5 and 4 s), but failed to replicate the respective finding in another study ([@nsx103-B40]). [@nsx103-B49] detected suppressed amygdala activity in GAD patients relative to HC during periods of uncertainty in a monetary loss task. Yet, these studies did not investigate sustained activation to threat. Importantly, while initial evidence of deviant amygdala activity during periods of uncertainty exists, the role of BNST in sustained responses to threat anticipation in GAD remains unresolved.

When investigating BNST activity in the context of sustained anticipatory anxiety, threat anticipation paradigms proved a powerful tool, since they allow to differentiate between phasic and sustained threat responding ([@nsx103-B13]). Threat anticipation paradigms parallel instructed fear conditioning tasks in that participants are made aware of the cue---stimuli pairings prior to actually experiencing it. The acquired predictive value of the cue is hold to produce an expectation of an aversive event that lasts until the delivery of the aversive event ([@nsx103-B34]). Concordantly, instructing participants that a specific cue will be followed by a threat stimulus is assumed to be sufficient to induce anticipatory anxiety responses ([@nsx103-B33]; [@nsx103-B15]). Moreover, previous investigations emphasized the necessity to explore different forms of sustained threat responding. While several studies on anticipatory anxiety detected sustained BNST activity starting with threat anticipation onset ([@nsx103-B44]; [@nsx103-B24]; [@nsx103-B7]), another study observed sustained BNST activity that was delayed relative to the onset of threat anticipation ([@nsx103-B32]). The latter finding is in line with the influential neurobiological model of sustained anxiety that postulates the BNST to show a delayed engagement relative to threat onset (Davis et al., 2010b). Another important aspect in BNST investigations constitutes the predictability of threat exposure, because it proved important to induce temporal unpredictability of threat exposure to ease detecting robust condition differences in BNST activity when present ([@nsx103-B20]; [@nsx103-B2]).

The current functional magnetic resonance imaging (fMRI) study sought to delineate temporal characteristics of the BNST and the amygdala engagement in GAD patients relative to HC during an instructed unpredictable threat anticipation paradigm. Warning cues were present during the entire anticipatory epoch, which either indicated a threatening (e.g. female screams) or neutral (e.g. water sounds) upcoming stimulus with 100% contingency. Anticipatory epochs varied in length, so that the appearance of the sounds was temporally unpredictable. Additionally, we defined phasic and a systematic variation of sustained response models for blood oxygen level-dependent responses (BOLD) during threat anticipation, to disentangle temporally dissociable involvement of the BNST and the amygdala. Given our current research focus, we concentrated on group differences in the amygdala and the BNST. Based on previous reports ([@nsx103-B39]; [@nsx103-B49]) we expected phasic amygdala activity alterations in GAD patients relative to HC during threat anticipation. With regard to the neurobiological model described above and former preliminary considerations ([@nsx103-B49]; [@nsx103-B25]), we expected GAD patients relative to HC to show heightened BNST activity to sustained threat anticipation.

Materials and methods
=====================

Subjects
--------

Nineteen GAD patients (male *n* = 4) and 19 HC (male *n* = 4) matched for education, age and gender were recruited through public advertisements and an outpatient clinic ([Table 1](#nsx103-T1){ref-type="table"}). Patients met criteria for GAD as primary diagnosis assessed by an experienced psychologist by means of the Structured Clinical Interview for Diagnostic and Statistical manual of Mental Disorders IV (DSM-IV) axis-I Disorders ([@nsx103-B48]). The Penn-State Worry Questionnaire (PSWQ) ([@nsx103-B35]) and the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) ([@nsx103-B37]) supported the diagnosis. Level of depressive symptoms was assessed by the Beck Depression Inventory-II (BDI) ([@nsx103-B3]). Representative of the GAD population, the patient sample had the following axis-I comorbidities ([@nsx103-B38]): recurrent major depressive disorder (*n *=* *3), posttraumatic stress disorder (PTSD) (*n *=* *1), specific phobia (*n *=* *1), eating disorder (*n *=* *1). Seven GAD patients took long-term medication. Participants gave written informed consent and had normal or corrected-to-normal vision. Exclusion criteria were neurological disorders, presence or history of psychotic or bipolar disorders, current drug abuse or dependence, and fMRI contraindications. The study was approved by the local ethics committee and conformed to the latest declaration of Helsinki. Table 1.Demographic and clinical characterization of GAD patients and HCGAD patientsHCStatisticsAge*M* = 28.26, *SD* = 8.93*M* = 28.00, *SD* = 5.28*F*~\[1,36\]~ = 0.11, *P* = 0.913Education (years at school)*M* = 12.63, *SD* = 1.57*M* = 12.89, *SD* = 0.81*F*~\[1,36\]~ = −0.65, *P* = 0.520BDI*M* = 18.00, *SD* = 12.67*M* = 1.11, *SD* = 2.00PSWQ*M* = 65.58, *SD* = 8.29GAD-Q-IV*M* = 9.94, *SD* = 1.41medication intake (*n*)70*--*[^1]

Stimuli
-------

Representative 4-s duration sequences were taken from sound clips of the International Affective Digitized Sounds database ([@nsx103-B4]). Three different human screams served as threat stimuli and three different water sounds as neutral stimuli. All stimuli had a constant intensity level. Hash or percent signs presented on a screen served as cues during threat or neutral anticipation epochs.

Experimental design
-------------------

An instructed, unpredictable threat anticipation paradigm, paralleling instructed fear conditioning tasks, was used during functional MRI, with 11 threat and 11 neutral trials. Each trial consisted of an anticipatory epoch and a sound being played for 4 s. Prior to scanning participants, were exposed to all sounds and informed that, for example, a hash sign indicated a threat trial at some unpredictable point followed by a scream sound ('threat anticipation'), whereas, for example, a percent sign indicated a neutral trial ('neutral anticipation'). Cues were counterbalanced across participants. The occurrence of the sounds was unpredictable due to the length variation of the anticipatory epoch: seven 16 s, one 10 s, one 5 s and two 3 s anticipatory epochs were used for the 11 threat and 11 neutral trials each. The limited trial number was based on previous evidence that amygdala responses rapidly habituate to conditioned or instructed fear cues ([@nsx103-B45]; [@nsx103-B24]), leading to power decline to detect amygdala activation with further repetitions. Warning cues were present throughout the entire anticipatory epoch. During inter-stimulus intervals a white fixation cross on black background was shown for 15 s. Following scanning, participants rated cues and sounds on 9-point Self-assessment manekin scales on the dimensions of arousal (1 = *not arousing at all*, 9 = *highly arousing*), valence (1 = *very negative*, 5 = *neutral*, 9 = *very positive*), and anxiety (1 = *not anxiety-inducing*, 9 = *highly anxiety-inducing*) ([@nsx103-B5]).

Data acquisition and analysis
-----------------------------

Analysis of sociodemographic, clinical questionnaire and rating data was performed using IBM SPSS software (v22, Armonk, New York, USA). Rating data for threat and neutral cues and sounds on the dimensions anxiety, arousal and valence were subjected to separate 2 (*cue*: threat, neutral) by 2 (*group*: GAD, HC) or 2 (*sound*: threat, neutral) by 2 (*group*: GAD, HC) mixed model analysis of variance (ANOVA). A probability level of *P* \< 0.05 was considered statistically significant and, Bonferroni-corrected *t*-tests were applied to resolve interaction effects (corrected significance level *P* \< 0.008).fMRI data, including anatomical and functional data, were acquired using a 3 Tesla magnetic resonance scanner ('Magnetom PRISMA', Siemens, Erlangen, Germany) with a 20 channel head-neck coil. A high-resolution T1-weighted anatomical scan with 192 slices and functional data with a T2\*-weighted echo-planar sequence (TE = 30 ms, flip angle = 90°, matrix = 92 × 92 voxels, FOV = 208 mm^2^, TR = 2080 ms) were acquired. Functional data consisted of 340 volumes with 36 axial slices (thickness = 3 mm, 0.3 mm gap, in plane resolution = 2.26 mm × 2.26 mm). fMRI data were preprocessed and analyzed using BrainVoyager QX (BVQX, v2.8, Brain Innovation, Maastricht, Netherlands). The first four volumes were discarded to ensure steady-state tissue magnetization, and data were corrected for slice time errors and movement artifacts. fMRI data were co-registered and normalized to Talairach space ([@nsx103-B46]), and smoothed both spatially (6 mm full-width half maximum \[FWHM\] Gaussian kernel) and temporally (high pass filter: 10 cycles per run; low pass filter: 2.8 s; linear trend removal). Volumes were resampled 2 × 2 × 2 mm voxel size.

Signal time course of every voxel was analyzed for each participant using multiple regression models in BrainVoyager. Brain responses during threat and neutral anticipatory epochs as well as brain responses to threat and neutral sounds were modeled by a canonical double-gamma hemodynamic response function (HRF). The processed data were analyzed using different general linear models (GLMs) to systematically explore phasic and sustained brain responses to threat anticipation. For the Phasic Response GLM, brain responses were modeled as HRFs elicited by the first second of anticipation. To systematically explore the time course of sustained brain activation during threat anticipation, we used models with a stepwise increasingly delayed onset of the HRF (Sustained Response GLMs). However, independently of delay each predictor modeled a sustained response spanning the whole remaining anticipatory interval. In the Sustained Response GLMs, onset was varied from 0 to 10 s in steps of 2 s, including trials with 16 s anticipatory epochs only. An additional modeling of the function that best described the resulting statistical values allowed to estimate the onset of the differential BNST time course between patients and controls (see [Figure 3](#nsx103-F3){ref-type="fig"}). All GLMs included additional regressors corresponding to threat and neutral sounds and six motion covariates defined as predictors of no interest. Next, %-standardized predictor estimates based on voxel-wise statistical maps were used for random effects analysis across groups. Given a-priori interest in the role of the amygdala and the BNST for the Phasic and Sustained Response GLMs, analyses were small-volume-corrected for anatomically defined regions of interest (ROIs). Based on the pathological anticipatory anxiety and GAD literature (see introduction), we were primarily interested in phasic amygdala and sustained BNST responding to threat anticipation. Furthermore, the amygdala is postulated to mediate long-lasting threat responding ([@nsx103-B10]) and the BNST was recently hypothesized to be involved during brief threat exposure as well ([@nsx103-B22]; [@nsx103-B41]). For the sake of completeness, we therefore additionally explored amygdala activity in the Sustained Response GLM and BNST activity in the Phasic Response GLM, yet, without expecting differential brain activity. Since the different ROIs were used for separate hypotheses, we did not correct for the number of ROIs. The ROI for the bilateral amygdala was defined based on the Automated Anatomical Labeling (AAL) atlas included in the Wake Forest University PickAtlas software ([@nsx103-B47]; [@nsx103-B30]; [@nsx103-B31]) and transformed into Talairach space ([@nsx103-B27]) using ICBM2TAL in Matlab (v8.2, The MathWorks Inc, Natick, Massachusetts, USA). The ROI for the bilateral BNST was defined based on an anatomical atlas (see [Supplementary material](#sup1){ref-type="supplementary-material"}) ([@nsx103-B29]; [@nsx103-B24]).

Correction for multiple comparisons was performed using a cluster-based permutation (CBP) approach ([@nsx103-B11]). The non-parametric method of CBP requires no assumption about the distribution of the test statistic, and results in precise false discovery rates ([@nsx103-B11]). Voxel-level threshold was set to *P* \< 0.005. We investigated pairwise group (GAD, HC) by anticipation epoch (threat, neutral) interactions. Permutation tests were performed with 1000 permutations. For each permutation, individual beta maps (including the anticipation effect: threat anticipation minus neutral anticipation) were randomly assigned without replacement to one of the two groups. Cluster mass was assessed by summing all *t*-values (or in case of correlational analyses Fisher's z-transformed correlation coefficients) in neighboring significant voxels. Next, the observed cluster mass was compared with the distribution of the maximum cluster mass observed in each of the 1000 permutations. Finally, cluster masses larger or equal to the 95th percentile of the permutation distribution were considered as statistically significant cluster (i.e. *P*(cluster) \< 0.05). Correlation analyses were performed for BDI, PSWQ, subjective ratings and medication intake in patients. To examine whether differential brain effects were maintained after inclusion of subjective ratings as covariates, 2 (anticipation: threat *vs* neutral anticipation) × 2 (group: GAD patients *vs* HC) analyses of covariance (ANCOVA) were performed separately for each rating as a covariate (anxiety-inducing, arousal, valence).

Results
=======

Rating data
-----------

[Figure 1](#nsx103-F1){ref-type="fig"} displays mean ratings for (threat/neutral) sounds and (threat/neutral) cues. Collapsed over groups, threat sounds were rated as more arousing, more negative and more anxiety-inducing than neutral sounds (main effect *sound*: arousal *F*(1,36) = 160.29, *P* \< 0.001; valence: *F*(1,36) = 408.00, *P* \< 0.001; anxiety: *F*(1,36) = 129.36, *P* \< 0.001). GAD patients rated both threat and neutral sounds as more arousing, more negative and more anxiety-inducing than HC (main effect *group*: arousal: *F*(1,36) = 11.74, *P* = 0.002; valence: *F*(1,36) = 9.17, *P* = 0.005, anxiety: *F*(1,36) = 11.21, *P* = 0.002). There was a significant interaction effect on the dimension of anxiety (*group* × *sound* interaction: *F*(1,36) = 9.21, *P* = 0.004). More specifically, GAD patients rated threat sounds as more anxiety-inducing as compared to HC, while there were no rating differences between groups regarding neutral sounds (threat sounds: *t*(36) = 3.24, *P* = 0.003, neutral sound: *n.s.*).

![Rating data. Mean ratings for (threat/neutral) sounds and (threat/neutral) cues on a 9-point Self-assessment manekin scale on the dimensions arousal (1 = *not arousing at all*, 9 = *highly arousing*), valence (1 = *very negative*, 5 = *neutral*, 9 = *very positive*), and anxiety (1 = *not anxiety-inducing*, 9 = *highly anxiety-inducing*). Generalized anxiety disorder (GAD) patients relative to healthy controls (HC) rated threat sounds as more anxiety-inducing and threat cues as more negative. \**P* \< 0.008.](nsx103f1){#nsx103-F1}

Collapsed over groups, threat cues were rated as more arousing, more negative and more anxiety-inducing than neutral cues (main effect *cues*: arousal: *F*(1,36) = 10.08, *P* = 0.003; valence: *F*(1,36) = 15.91, *P* \< 0.001; anxiety: *F*(1,36) = 20.37, *P* \< 0.001). GAD patients rated cues as more arousing, more negative and more anxiety-inducing than HC (main effect *group*: arousal: *F*(1,36) = 17.49, *P* \< 0.001; valence: *F*(1,36) = 9.69, *P* = 0.004; anxiety: *F*(1,36) = 7.97, *P* = 0.008). There was a significant interaction effect on the dimension of valence (*group* × *cues* interaction: *F*(1,36) = 5.56, *P* = 0.024). More precisely, threat cues were rated by GAD patients as more negative as compared to HC, while there were no rating differences between groups regarding neutral cues (threat cue: *t*(36) = −3.75, *P* = 0.001, neutral cue: *n.s.*).

fMRI analysis
-------------

*Phasic Response GLM:* GAD patients relative to HC responded to threat minus neutral anticipation with increased phasic activation in the right amygdala (peak voxel Talairach coordinates: *x* = 29, *y* = −1, *z* = −19; size: 296 mm³; maximal *t*-value: 3.64 average *t*-value: 3.06; *P* \< 0.05 corrected) ([Figure 2](#nsx103-F2){ref-type="fig"}). Activity in the functionally defined amygdala cluster showed no correlation with medication intake, subjective ratings, PSWQ or BDI scores in patients. There were no significant effects in the BNST. The influence of subjective ratings were tested by means of ANCOVAs and unveiled maintained *interaction* effects (all *F*-values ≥ 12.45, all *p ≤ *.001) and no significant effects of the covariates (all *P* \> 0.05).

![Elevated amygdala activity to threat minus neutral anticipation in patients relative to healthy controls. (**A**) Generalized anxiety disorder (GAD) patients relative to healthy controls (HC) responded with elevated phasic activity in the right amygdala. (**B**) Time courses of the blood oxygen level-dependent (BOLD) signal change, extracted from the amygdala cluster and averaged across time points and participants per group, are displayed for the anticipatory epoch (threat minus neutral anticipation) starting 4 s before cue onset.](nsx103f2){#nsx103-F2}

*Sustained Response GLMs:* We detected elevated BNST activity to threat minus neutral anticipation in GAD patients as compared to HC in the 4, 6, 8 and 10 s Sustained Response GLMs in the right BNST in an highly overlapping cluster with maximal *t*-values varying between 3.14 and 3.46, average *t*-values between 2.92 and 3.12, and cluster sizes between 96 and 144 mm^3^ ([Table 2](#nsx103-T2){ref-type="table"} and [Figure 3](#nsx103-F3){ref-type="fig"}). There was no differential BNST activity in the 0, and 2-s Sustained Response GLM. As indicated in [Figure 3](#nsx103-F3){ref-type="fig"}, the mean statistical values for the contrast threat minus neutral anticipation in GAD patients as compared to HC extracted from the overlapping cluster of all significant Sustained Response GLMs, followed a highly significant quadratic function with the delay of the sustained response predictor (function: *y* = −0.022*x*^2^ + 0.297*x* + 2.291, *R*^2^ = 0.96, *P* \< 0.007). The vertex of the function was at 6.69 s, suggesting a delayed onset of about 6--7 s of the differential sustained BNST effect. Activity in the functionally defined BNST cluster showed no correlation with medication intake, subjective ratings, PSWQ or BDI scores in patients. The influence of subjective ratings were tested by means of ANCOVAs and unveiled maintained *interaction* effects (all *F*-values ≥ 10.49, all *P≤* 0.003) and no significant effects of the covariates (all *P* \> 0.05). There were no significant effects in the amygdala. Table 2.Significant effects for the contrast threat minus neutral anticipation in GAD patients as compared to HC in the right bed nucleus of the stria terminalisDelayed-Sustained Response GLM*xyz*Average *t*-valueMaximal *t*-valuemm^3^4-s63−22.973.221206-s4−1−23.123.461448-s4−1−23.063.4414410-s4−1−22.923.1496[^2]

![Elevated bed nucleus of the stria terminalis activity to threat minus neutral anticipation in patients relative to healthy controls. (**A**) Generalized anxiety disorder (GAD) patients relative to healthy controls (HC) responded with elevated sustained, but delayed bed nucleus of the stria terminalis (BNST) activity to threat minus neutral anticipation for all Sustained Response General Linear Models (GLM) with a delayed onset of at least 4 s in a highly overlapping cluster. (**B**) Time courses of the blood oxygen level-dependent (BOLD) signal change, extracted from the overlapping BNST cluster (of the 4, 6, 8 and 10 s Sustained Response GLMs) and averaged across time points and participants per group, are displayed for the anticipatory epoch (threat minus neutral anticipation) starting 4 s before cue onset. (**C**) Quadratic regression analyses on the average *t*-values for the contrast threat minus neutral anticipation in GAD patients as compared to HC extracted from the overlapping cluster of all significant Sustained Response GLMs, revealed a significant quadratic relationship. The vertex of the function was at 6.69 s, suggesting a delayed onset of about 6--7 s of the differential sustained BNST effect. The lower graph displays all Sustained Response Models. \**P* \< 0.05.](nsx103f3){#nsx103-F3}

Discussion
==========

The present study explored phasic and sustained brain responses to threat anticipation in GAD patients relative to HC in an instructed threat anticipation paradigm with temporally unpredictable threat exposure. As predicted, GAD patients compared to HC responded with heightened phasic activity in the amygdala. Furthermore, we detected enhanced BNST activity in GAD patients relative to HC that emerged delayed, relative to threat anticipation onset. Rating data showed that GAD patients rated threat anticipation as more negative and threat sounds as more anxiety-inducing than HC.

Our findings provide first evidence of a temporal dissociation of BNST and amygdala activity during threat anticipation in GAD patients. Importantly, GAD patients showed significantly heightened delayed-sustained BNST activity during unpredictable threat anticipation. Enhanced BNST activity appears to reflect elevated physiological and subjective emotional responses to uncertainty (for review see [@nsx103-B2]; [@nsx103-B28]). Also, BNST engagement seems to be related to the ability to differentiate between safe and non-safe-contexts (for review see [@nsx103-B28]). Thus, elevated sustained BNST activity to threat anticipation in GAD patients suggests that upcoming threat exposure may have been particularly aversive to them, which is in line with results of rating data. This fits with hypersensitivity and exaggerated apprehensive responding to threat in GAD patients, shown with a startle paradigm ([@nsx103-B19]). Yet, former studies did not report significant differential BNST activity in GAD patients relative to HC ([@nsx103-B39]; [@nsx103-B40]). Depending on study design and analysis, absent differential BNST activity may be attributable to short anticipatory epochs, predictable onset of threat, unsuited HRF models, or reduced differentiation between aversive and neutral stimuli, for example in (not instructed) fear conditioning designs ([@nsx103-B18]). Nevertheless, our results support previous findings of delayed-sustained BNST engagement ([@nsx103-B32]), postulations of an influential neurobiological model ([@nsx103-B10]), and encourage future studies to consider different temporal aspects of BNST activation during threat anticipation.

GAD patients responded also with exaggerated amygdala activity to threat anticipation onset, which is in line with a previous study ([@nsx103-B39]). Amygdala activity appears to be essential for phasic attention-vigilance aspects of threat processing and immediate threat detection ([@nsx103-B12]). Phasic hyperreactive amygdala responding may indicate that GAD patients were particular vigilant and attentive towards upcoming threat ([@nsx103-B21]), which fits with behavioral evidence from GAD patients showing an attentional bias towards threatening information (for review see [@nsx103-B23]). Such an information processing bias eases the perception of danger, and possibly contributes to heightened threat expectancies ([@nsx103-B23]; [@nsx103-B21]). Biased threat expectancies under conditions of uncertainty are proposed to initiate a vicious circle that may result in prolonged anxious threat apprehension in GAD patients ([@nsx103-B21]), which may be reflected by enhanced BNST engagement.

Elevated phasic amygdala and sustained BNST activity to threat anticipation was unveiled in previous studies in specific phobia, panic disorder or PTSD patients ([@nsx103-B44]; [@nsx103-B36]; [@nsx103-B6], [@nsx103-B7], [@nsx103-B8]). Interestingly, the above reported studies detected elevated BNST activity to threat anticipation onset, while in GAD patients elevated BNST activity emerged delayed relative to threat anticipation onset. Together, these observations lend support for two notions: First of all, it appears that elevated phasic amygdala and sustained BNST activity during anxious apprehension constitute translational pathological brain response patterns cutting across anxiety/stress disorders. Interestingly, both the amygdala and the BNST received prominent attention within the addiction disorder literature as well (for review see [@nsx103-B43]; [@nsx103-B2]). More specifically, it is hold that both structures mediate the stage of withdrawal/negative affect that is defined by lasting increases in anxiety ([@nsx103-B17]). It may be speculated that anticipation of exposure to addiction-related stimuli might evoke altered amygdala and BNST activity in addiction disorder patients too. Second of all, the unique delayed time course of heightened BNST activity to threat anticipation in GAD might represent a disorder-specific response pattern. Yet, it remains to note that former investigations did not apply the here-reported analysis, leaving it to call into question whether this pattern is disorder-specific or not. Whether or not the pattern of delayed-sustained BNST engagement to threat anticipation is unique to GAD patients would require a direct comparison between psychiatric disorders.

Our findings of elevated amygdala and BNST engagement during unpredictable threat anticipation in GAD patients should be considered in light of the studýs strengths and limitations. As major strengths, we consider our instructed threat paradigm, and the methods of data analysis used ([@nsx103-B20]; [@nsx103-B32]; [@nsx103-B24]; [@nsx103-B7]). A limitation is that patients were medicated at time of testing and had comorbidities, which possibly constitute confounds. We carefully ensured that GAD was the main diagnosis for patients and since comorbidities are frequent in GAD, our sample is likely to be representative of the GAD population ([@nsx103-B38]). Also, correlation analyses showed no relationship between medication intake and increased amygdala or BNST activity in GAD patients. Nonetheless, investigations with patients that are off psychopharmacological medication and without comorbidities would be beneficial in future studies. Another drawback concerns absent correlational effects between differential brain responses and behavioral measures (e.g. subjective ratings, PSWQ) that could have strengthened the interpretations and provide further insight into the functional role of the BNST and the amygdala during pathological anticipatory anxiety. In addition to that, we recommend exploring the involvement of additional brain regions (e.g. anterior insula, anterior cingulate cortex, nucleus accumbens) in future studies, as these proved to be relevant during threat anticipation and instructed fear conditioning ([@nsx103-B26]; [@nsx103-B1]; [@nsx103-B20]; [@nsx103-B42]; [@nsx103-B24]).

To conclude, unpredictable threat anticipation induced heightened phasic amygdala and delayed-sustained BNST engagement in GAD patients relative to HC. Heightened phasic amygdala activity may point towards exaggerated attention-vigilance processing during early phases of threat anticipation. Information-processing biases may lead to heightened threat expectancies and initiate a vicious circle, resulting in prolonged anxious threat apprehension. Respective sustained threat anticipation may be reflected by heightened delayed-sustained BNST activity in GAD patients. Overall, the present results suggest that BNST and amygdala activity alterations may be useful neurobiological markers of anticipatory anxiety in GAD patients, albeit with different time courses.
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[^1]: Notes and Sources. GAD, generalized anxiety disorder; HC, healthy controls; BDI, Beck-Depression Inventory-II; PSWQ, Penn State Worry Questionnaire; GAD-Q-IV, Generalized Anxiety Disorder Questionnaire-IV.

[^2]: Notes and Sources: GAD, generalized anxiety disorder; HC, healthy controls; GLM, general linear model; *x*, *y*, *z*, Talairach coordinates of maximally activated voxel (*P* \< 0.05 corrected).
